Science Explorer Interactive view Map
Company · Birmingham · United States

Gem Pharmaceuticals (United States)

gempharmltd.co.ukROR OpenAlex
Research works
5
▼ 90% vs 2013–17
Citations
200
40.0 per fractional work
Top-10% rate
32.4%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Gem Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Which research topics does Gem Pharmaceuticals (United States) publish most on?

    By volume: Chemotherapy-induced cardiotoxicity and mitigation, Cancer Treatment and Pharmacology, Cancer, Hypoxia, and Metabolism and Autophagy in Disease and Therapy.

    Chemotherapy-induced car…1Chemotherapy-induced cardiotoxicity and mitigation: 1 fractional worksCancer Treatment and Pha…0Cancer Treatment and Pharmacology: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksAutophagy in Disease and Therapy: 0 fractional worksElectron Spin Resonance Studies: 0 fractional worksLung Cancer Research Studies: 0 fractional worksSynthesis and Biological Evaluation: 0 fractional worksNuclear Receptors and Si…0Nuclear Receptors and Signaling: 0 fractional worksBlood disorders and trea…0Blood disorders and treatments: 0 fractional worksHistone Deacetylase Inhi…0Histone Deacetylase Inhibitors Research: 0 fractional works
    Cardiology and Cardiovascular MedicineOncologyCancer ResearchEpidemiology5 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 1 works
    2. 2 Cancer Treatment and Pharmacology Oncology 0 works
    3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
    4. 4 Autophagy in Disease and Therapy Epidemiology 0 works
    5. 5 Electron Spin Resonance Studies Biophysics 0 works
    6. 6 Lung Cancer Research Studies Oncology 0 works
    7. 7 Synthesis and Biological Evaluation Organic Chemistry 0 works
    8. 8 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
    9. 9 Blood disorders and treatments Genetics 0 works
    10. 10 Histone Deacetylase Inhibitors Research Molecular Biology 0 works

    How open and international is its research?

    Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available50.3%not open49.7%

    World: 28% of research is openly available.

    with international co-authors15.9%domestic only84.1%

    World: 19% is written across borders.

    How has Gem Pharmaceuticals (United States)'s research output changed?

    Output in 2018–2022 was 90% lower than in 2013–2017.

    200520102015
    grewheldshrank

    The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

    Other research institutions in Birmingham

    All research institutions in Birmingham

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.